Advertisement

Topics

Aestus Pharmaceuticals Corp Company Profile

01:54 EDT 22nd June 2018 | BioPortfolio

Aestus is a cGMP manufacturer of products for the pharmaceutical and biotechnology industries. In addition to manufacturing diagnostic reagents and pharmaceutical products under the Aestus brand name, our company also offers products on a private-label, contract manufacturing basis.
Our products, formulated with the highest quality reagents, are subjected to stringent quality standards to provide consistent results for your diagnostic and research needs.

While we strive to offer our customers a wide range of products, should you require a product that is not listed on our website, please contact us for our customized services.

Location

17-145 Royak Crest Cort
Markham
Ontaria
L3R9Z4
Canada

Contact

Phone: (905)35 6794
Fax: (905)773 6286
Email: info@aestuspharm.com


News Articles [551 Associated News Articles listed on BioPortfolio]

Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results

ANN ARBOR, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical co...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results

ANN ARBOR, Mich., May 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical compa...

pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.

Acquisition and additional funding significantly accelerate the company’stransformation to a specialty biopharmaceutical company with the potential tocommercialize two ophthalmic products in 1H 2...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.

Pharmaceuticals are found in freshwater ecosystems where even low concentrations in the range of ng Lmay affect aquatic organisms. In the current study, we investigated the effects of chronic exposure...

Clinical Trials [217 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1362 Associated Companies listed on BioPortfolio]

Aestus Therapeutics and Prosidion Ltd.

Aestus Therapeutics, Inc. is a translational medicine company focused on serious neurological diseases. Capitalizing on genomic data analysis to discover novel links between these...

Aestus Pharmaceuticals Corp

Aestus is a cGMP manufacturer of products for the pharmaceutical and biotechnology industries. In addition to manufacturing diagnostic reagents and pharmaceutical products under the Aestus brand name,...

Aestus Therapeutics, Inc.

Aestus Therapeutics, Inc. is a translational medicine company focused on serious neurological diseases. Capitalizing on genomic data analysis to discover novel links between these...

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

More Information about "Aestus Pharmaceuticals Corp" on BioPortfolio

We have published hundreds of Aestus Pharmaceuticals Corp news stories on BioPortfolio along with dozens of Aestus Pharmaceuticals Corp Clinical Trials and PubMed Articles about Aestus Pharmaceuticals Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aestus Pharmaceuticals Corp Companies in our database. You can also find out about relevant Aestus Pharmaceuticals Corp Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record